Drug Shortage Report for POLLINEX R
Report ID | 140460 |
Drug Identification Number | 00464988 |
Brand name | POLLINEX R |
Common or Proper name | Modified ragweed tyrosine adsorbate |
Company Name | ALLERGY THERAPEUTICS (UK) LTD |
Market Status | MARKETED |
Active Ingredient(s) | MODIFIED RAGWEED TYROSINE ADSORBATE |
Strength(s) | 4300UNIT |
Dosage form(s) | LIQUID |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | 4 syringes/4 vials |
ATC code | V01AA |
ATC description | ALLERGENS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-07-29 |
Actual start date | 2021-06-02 |
Estimated end date | 2021-06-21 |
Actual end date | 2021-07-29 |
Shortage status | Resolved |
Updated date | 2021-08-05 |
Company comments | This case is now closed, AllergyTherapeutics confirm no further shortage for Pollinex R,resupply commenced 29th Jul 2021 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | DOMINION WAY WORTHING, WEST SUSSEX UNITED KINGDOM BN14 8SA |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2021-08-05 | French | Compare |
v3 | 2021-08-05 | English | Compare |
v2 | 2021-06-04 | French | Compare |
v1 | 2021-06-04 | English | Compare |
Showing 1 to 4 of 4